This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rappaport, S. M. Articles by Li, K. Search for Related Content PubMed PubMed Citation Articles by Rappaport, S. M. Articles by Li, K.

Albumin Adducts of Benzene Oxide and 1,4-Benzoquinone as Measures of Human Benzene Metabolism¹

School of Public Health, University of North Carolina, Chapel Hill, North Carolina 27599-7400 [S. M. R., S. W.]; Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, New York 10987 [Q. Q., R. S., X. J., B. C., L-C. C.]; American Health Foundation, Valhalla, New York 10595 [A. A. M.]; Chinese Academy of Preventive Medicine, Institute for Occupational Medicine, Beijing, 100050 China [G. L., S. Y., H. Y., B. X.]; Tianjin Institute of Industrial Health and Occupational Medicine, Tianjin, 300204 China [R. M., Y. L.]; Tianjin Hebei District Antiepidemic Station, Tianjin, 300400 China [X. Z.]; and Wuqing County Antiepidemic Station, Tianjin, 301700 China [K. L.]

Albumin adducts of benzene oxide (BO-Alb) and 1,4-benzoquinone (1,4-BQ-Alb) were investigated among 134 workers exposed to benzene and 51 unexposed controls in Tianjin, China. Concentrations of both adducts increased with benzene exposure [range = 0.07–46.6 parts/million (ppm); median = 3.55 ppm] and with urinary cotinine. Adduct levels were less than proportional to benzene exposure, suggesting saturable CYP 2E1 metabolism of benzene. Because the transition from linear to saturable metabolism began at 1 ppm, the common assumption of linear kinetics at much higher benzene exposures could lead to substantial underestimation of leukemia risks. Adduct levels were generally lower in older workers, indicating that CYP 2E1 metabolism diminished with age, at 2%/year of life. The ratio of 1,4-BQ-Alb:BO-Alb decreased with age and coexposure to toluene, and increased with alcohol consumption. This indicates that factors affecting CYP 2E1 metabolism exerted a greater role on production of 1,4-BQ than BO, presumably because of the second oxidation step from phenol to hydroquinone. The adduct ratio was also positively associated with urinary cotinine, suggesting that both benzene and hydroquinone from cigarette smoke affected adduct levels. Results of a limited time course study of 11 subjects indicated moderate chemical instability of 1,4-BQ-Alb (half life = 13.5 days compared with 21 days for normal Alb turnover), whereas no evidence of instability of BO-Alb was observed. This study illustrates that Alb adducts can be used to investigate the dispositions of reactive metabolites of procarcinogens in humans, provided that exposures are adequately characterized in the month preceding blood collection.

This article has been cited by other articles:

				J. E. Deweese and N. Osheroff The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing Nucleic Acids Res., February 1, 2009; 37(3): 738 - 748. [Abstract] [Full Text] [PDF]

				W. E. Funk, S. Waidyanatha, S. H. Chaing, and S. M. Rappaport Hemoglobin Adducts of Benzene Oxide in Neonatal and Adult Dried Blood Spots Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 1896 - 1901. [Abstract] [Full Text] [PDF]

				S Wilbur, D Wohlers, S Paikoff, L. Keith, and O Faroon ATSDR evaluation of health effects of benzene and relevance to public health Toxicology and Industrial Health, June 1, 2008; 24(5-6): 263 - 398. [Abstract] [PDF]

				S. Kim, R. Vermeulen, S. Waidyanatha, B. A. Johnson, Q. Lan, M. T. Smith, L. Zhang, G. Li, M. Shen, S. Yin, et al. Modeling Human Metabolism of Benzene Following Occupational and Environmental Exposures. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2246 - 2252. [Abstract] [Full Text] [PDF]

				S. Kim, R. Vermeulen, S. Waidyanatha, B. A. Johnson, Q. Lan, N. Rothman, M. T. Smith, L. Zhang, G. Li, M. Shen, et al. Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism Carcinogenesis, April 1, 2006; 27(4): 772 - 781. [Abstract] [Full Text] [PDF]

				X. Wang, B. Thomas, R. Sachdeva, L. Arterburn, L. Frye, P. G. Hatcher, D. G. Cornwell, and J. Ma Mechanism of arylating quinone toxicity involving Michael adduct formation and induction of endoplasmic reticulum stress PNAS, March 7, 2006; 103(10): 3604 - 3609. [Abstract] [Full Text] [PDF]

				Y S Lin, L L Kupper, and S M Rappaport Air samples versus biomarkers for epidemiology Occup. Environ. Med., November 1, 2005; 62(11): 750 - 760. [Abstract] [Full Text] [PDF]

				S. M. Rappaport, L. L. Kupper, and Y. S. Lin On the Importance of Exposure Variability to the Doses of Volatile Organic Compounds Toxicol. Sci., February 1, 2005; 83(2): 224 - 236. [Abstract] [Full Text] [PDF]

				S. Waidyanatha, Y. Zheng, B. Serdar, and S. M. Rappaport Albumin Adducts of Naphthalene Metabolites as Biomarkers of Exposure to Polycyclic Aromatic Hydrocarbons Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 117 - 124. [Abstract] [Full Text] [PDF]

				G. Marrubini, A. F. Castoldi, T. Coccini, and L. Manzo Prolonged Ethanol Ingestion Enhances Benzene Myelotoxicity and Lowers Urinary Concentrations of Benzene Metabolite Levels in CD-1 Male Mice Toxicol. Sci., September 1, 2003; 75(1): 16 - 24. [Abstract] [Full Text] [PDF]